Bioethics News

The Next Health Fad? Blood Transfusions from Young People

August 3, 2016

(MIT Technology Review) – The latest advancement in anti-aging therapies hardly sounds like modern medicine at all. Ambrosia, a startup based in Monterey, California, is launching a clinical trial to inject the blood of young people into just about anyone aged 35 and up—if they’re willing to pay $8,000. Young-to-old blood transfusions hit the limelight in 2014 when Harvard Stem Cell Institute researcher Amy Wagers discovered that the blood of young mice improved muscle, heart, and brain function in older mice. Scientists sewed the skin of two mice together, allowing their circulatory systems to merge. The surgery, called parabiosis, was first performed in the 1860s but has seen a resurgence of interest following Wagers’s study.

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.